Recurrent anterior uveitis induced by multiple systemic injections of muramyl dipeptide.


The development of new therapeutic modalities in the treatment of uveitis has been greatly aided by the availability of suitable animal models. The endotoxin model excellently mimics many features of acute anterior uveitis. A new model that exhibits many features of recurrent anterior uveitis is described here. Muramyl dipeptide, MDP, is a synthetic monomer… (More)


  • Presentations referencing similar topics